Wegovy vs Eli Lilly’s Foundayo: a head to head comparison A new cross trial comparison from Novo Nordisk argues that its weight loss drug Wegovy (injectable semaglutide) produces more weight loss than Eli Lilly’s oral obesity pill, Foundayo (oral semaglutide) . The comparison is framed around…
Continue reading...
Continue reading...